Britain’s largest pharmaceutical company, AstraZeneca, has revealed plans to invest $2.5 billion in Beijing, signalling its commitment to expanding operations in its second-largest market despite ongoing controversies. The announcement showcases
Britain’s largest pharmaceutical company, AstraZeneca, has revealed plans to invest $2.5 billion in Beijing, signalling its commitment to expanding operations in its second-largest market despite ongoing controversies. The announcement showcases






